The fund, MedArtha Capital, recently secured Sebi approval, plans to deploy capital over the next two-to-three years, backing 10-12 small but high-growth medtech companies.
The fund, MedArtha Capital, recently secured Sebi approval, plans to deploy capital over the next two-to-three years, backing 10-12 small but high-growth medtech companies.